Combined modality immunotherapy and chemotherapy: a new perspective

被引：53

作者：

Ramakrishnan, Rupal ^{[1
]}

Antonia, Scott ^{[1
]}

Gabrilovich, Dmitry I. ^{[1
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA

来源：

CANCER IMMUNOLOGY IMMUNOTHERAPY | 2008年 / 57卷 / 10期

关键词：

D O I：

10.1007/s00262-008-0531-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The results of recent clinical trials have demonstrated that cancer vaccines continue to struggle to achieve tangible clinical benefits as monotherapy. Tumor-induced abnormalities in the immune system hamper anti-tumor T cell responses limiting the effectiveness of cancer immunotherapy. Recently, evidence has been mounting to suggest that immunotherapy has the possibility of achieving better success when used in combination with conventional chemotherapy. In clinical trials, immune responses elicited by cancer vaccines appear to augment the effectiveness of subsequent conventional cancer therapies.

引用

页码：1523 / 1529

页数：7

共 61 条

[1] Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer [J].

Almand, B ;

Clark, JI ;

Nikitina, E ;

van Beynen, J ;

English, NR ;

Knight, SC ;

Carbone, DP ;

Gabrilovich, DI .

JOURNAL OF IMMUNOLOGY, 2001, 166 (01) :678-689

[2] How Taxol® stabilises microtubule structure [J].

Amos, LA ;

Löwe, J .

CHEMISTRY & BIOLOGY, 1999, 6 (03) :R65-R69

[3] Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer [J].

Antonia, SJ ;

Mirza, N ;

Fricke, I ;

Chiappori, A ;

Thompson, P ;

Williams, N ;

Bepler, G ;

Simon, G ;

Janssen, W ;

Lee, JH ;

Menander, K ;

Chada, S ;

Gabrilovich, DI .

CLINICAL CANCER RESEARCH, 2006, 12 (03) :878-887

[4] Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy [J].

Apetoh, Lionel ;

Ghiringhelli, Francois ;

Tesniere, Antoine ;

Obeid, Michel ;

Ortiz, Carla ;

Criollo, Alfredo ;

Mignot, Gregoire ;

Maiuri, M. Chiara ;

Ullrich, Evelyn ;

Saulnier, Patrick ;

Yang, Huan ;

Amigorena, Sebastian ;

Ryffel, Bernard ;

Barrat, Franck J. ;

Saftig, Paul ;

Levi, Francis ;

Lidereau, Rosette ;

Nogues, Catherine ;

Mira, Jean-Paul ;

Chompret, Agnes ;

Joulin, Virginie ;

Clavel-Chapelon, Francoise ;

Bourhis, Jean ;

Andre, Fabrice ;

Delaloge, Suzette ;

Tursz, Thomas ;

Kroemer, Guido ;

Zitvogel, Laurence .

NATURE MEDICINE, 2007, 13 (09) :1050-1059

[5] A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer [J].

Arlen, PM ;

Gulley, JL ;

Parker, C ;

Skarupa, L ;

Pazdur, M ;

Panicali, D ;

Beetham, P ;

Tsang, KY ;

Grosenbach, DW ;

Feldman, J ;

Steinberg, SM ;

Jones, E ;

Chen, C ;

Marte, J ;

Schlom, J ;

Dahut, W .

CLINICAL CANCER RESEARCH, 2006, 12 (04) :1260-1269

[6] Phosphorylation of BAD at Ser-128 during mitosis and paclitaxel-induced apoptosis [J].

Berndtsson, M ;

Konishi, Y ;

Bonni, A ;

Hägg, M ;

Shoshan, M ;

Linder, S ;

Havelka, AM .

FEBS LETTERS, 2005, 579 (14) :3090-3094

[7] IFN-γ- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers [J].

Bin Zhang ;

Karrison, Theodore ;

Rowley, Donald A. ;

Schreiber, Hans .

JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (04) :1398-1404

[8]

BODNER SM, 1992, ONCOGENE, V7, P743

[9] Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death [J].

Casares, N ;

Pequignot, MO ;

Tesniere, A ;

Ghiringhelli, F ;

Roux, S ;

Chaput, N ;

Schmitt, E ;

Hamai, A ;

Hervas-Stubbs, S ;

Obeid, M ;

Coutant, F ;

Métivier, D ;

Pichard, E ;

Aucouturier, P ;

Pierron, G ;

Garrido, C ;

Zitvogel, L ;

Kroemer, G .

JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (12) :1691-1701

[10] Combining cancer vaccines with chemotherapy [J].

Chong, G ;

Morse, MA .

EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (16) :2813-2820

← 1 2 3 4 5 6 7 →